{"title":"Macrophages mediate acute kidney allograft rejection via a toll-like receptor 4-dependent mechanism.","authors":"Qixia Shen,Tingting Zhu,Sijing Yan,Yucheng Wang,Cuili Wang,Lisha Teng,Shi Feng,Xiao-Ru Huang,Sydney C W Tang,Hongfeng Huang,Song Rong,Xiujin Shen,Lihui Qu,Zhouji Shen,Enyin Lai,Hui-Yao Lan,Jianghua Chen,Hong Jiang","doi":"10.1016/j.kint.2025.09.014","DOIUrl":null,"url":null,"abstract":"INTRODUCTION\r\nMacrophages play an important role in acute renal allograft rejection (RAR). Here we report that macrophages mediate acute RAR via a toll-like receptor 4 (TLR4)-dependent mechanism.\r\n\r\nMETHODS\r\nAcute RAR was induced in myeloid cell-specific TLR4 knockout mice. Rejection severity was assessed by Banff scores, kidney immune cell infiltration/activation, and kidney function. Mechanisms were investigated using single cell RNA sequencing (scRNA-seq) and pharmacological hypoxia-inducible factor (HIF)1α inhibition. Immune profiling evaluated macrophage polarization, antigen presentation and T cell subsets.\r\n\r\nRESULTS\r\nDisruption of myeloid TLR4 largely suppressed acute RAR, evidenced by lower Banff scores, inhibited kidney immune cell infiltration and activation, and preserved kidney function. scRNA-seq identified HIF1Α as a key downstream target of myeloid TLR4. Importantly, both genetic TLR4 ablation and pharmacological HIF1α inhibition attenuated acute RAR via reducing proinflammatory macrophages (F4/80+ iNOS+ and F4/80+ HIF1α+), suppressing antigen presenting by F4/80+MHCII+ macrophages and modulating T cell immunity by suppressing CD8+ T cells and Th1 cells, while expanding regulatory T cell and Th2 populations. Notably, targeting TLR4/HIF1α signaling also ameliorated fibrosis in long-term allograft rejection.\r\n\r\nCONCLUSIONS\r\nMacrophages mediate acute RAR via a TLR4/HIF1α-dependent mechanism. Targeting TLR4/HIF1α signaling may be a novel therapeutic strategy for acute RAR, with additional benefits mitigating chronic allograft injury.","PeriodicalId":17801,"journal":{"name":"Kidney international","volume":"9 1","pages":""},"PeriodicalIF":12.6000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kidney international","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.kint.2025.09.014","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
INTRODUCTION
Macrophages play an important role in acute renal allograft rejection (RAR). Here we report that macrophages mediate acute RAR via a toll-like receptor 4 (TLR4)-dependent mechanism.
METHODS
Acute RAR was induced in myeloid cell-specific TLR4 knockout mice. Rejection severity was assessed by Banff scores, kidney immune cell infiltration/activation, and kidney function. Mechanisms were investigated using single cell RNA sequencing (scRNA-seq) and pharmacological hypoxia-inducible factor (HIF)1α inhibition. Immune profiling evaluated macrophage polarization, antigen presentation and T cell subsets.
RESULTS
Disruption of myeloid TLR4 largely suppressed acute RAR, evidenced by lower Banff scores, inhibited kidney immune cell infiltration and activation, and preserved kidney function. scRNA-seq identified HIF1Α as a key downstream target of myeloid TLR4. Importantly, both genetic TLR4 ablation and pharmacological HIF1α inhibition attenuated acute RAR via reducing proinflammatory macrophages (F4/80+ iNOS+ and F4/80+ HIF1α+), suppressing antigen presenting by F4/80+MHCII+ macrophages and modulating T cell immunity by suppressing CD8+ T cells and Th1 cells, while expanding regulatory T cell and Th2 populations. Notably, targeting TLR4/HIF1α signaling also ameliorated fibrosis in long-term allograft rejection.
CONCLUSIONS
Macrophages mediate acute RAR via a TLR4/HIF1α-dependent mechanism. Targeting TLR4/HIF1α signaling may be a novel therapeutic strategy for acute RAR, with additional benefits mitigating chronic allograft injury.
期刊介绍:
Kidney International (KI), the official journal of the International Society of Nephrology, is led by Dr. Pierre Ronco (Paris, France) and stands as one of nephrology's most cited and esteemed publications worldwide.
KI provides exceptional benefits for both readers and authors, featuring highly cited original articles, focused reviews, cutting-edge imaging techniques, and lively discussions on controversial topics.
The journal is dedicated to kidney research, serving researchers, clinical investigators, and practicing nephrologists.